This will be interesting to follow. I wish Cytodyn was still working with Dr. BP. Lots of synergy here instead of two entities working seprately. We could actually use Dr. BP's diagnostics tools to screen for long hauler patients with the highest likelihood of benefitting from leronlimab. Thus ensuring that we hit the primary endpoint even in phase 2.

Dr. Yo
@YoDoctorYo

Monday morning feelings. We have the data that supports #COVID #longhaulers are suffering from a new immune pathology. Bruce did it. He absolutely did it- I saw the data myself. Report out in 2 weeks.

Let's light it up Fire

#Brucefigureditout